Trial intelligence / Profile preview

Dose effect of oxytocin during cesarean section with prophylactic deoxyepinephrine

ChiCTR2200059556Phase 4Not yet recruiting

Sponsor
Linping District Women and Children Care Hospital
Start
May 2022
Modality
Recombinant Proteins and Enzymes, Peptides
Countries
1
01

Overview

Phase 4, randomised trial of oxytocin in uterine atony and intraoperative hypotension (IOH) (4 arms), sponsored by Linping District Women and Children Care Hospital. Primary endpoint: Success rate of treating uterine atony. Planned start May 2022; status: not yet recruiting.

02

Drugs

oxytocin
03

Conditions

uterine atonyintraoperative hypotension (IOH)

Beyond the preview

Go deeper on ChiCTR2200059556.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2200059556.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call